Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 29
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
3/16/2006
 
First Published:
8/1/2001
1.
Phase III Randomized Study of Decitabine Versus Supportive Care in Patients With Advanced Myelodysplastic Syndromes
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
18 and over
Pharmaceutical / Industry
SUPERGEN-D-0007
ABCCC-010303, NCT00043381
Last Modified:
7/1/2000
2.
Phase I/II Study of Chemotherapy with High-Dose Decitabine, Busulfan, and Cyclophosphamide with Allogeneic Stem Cell Transplantation in Patients With Hematologic Malignancies (Summary Last Modified 07/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
15 to 55
NCI
MDA-DM-94064
NCI-G96-0999, NCT00002831
Last Modified:
7/12/2007
3.
Phase I/II Trial of Decitabine and Allogeneic Peripheral Blood Stem Cells Transplantation in Patients With Relapse Post Allogeneic Bone Marrow Transplantation (Summary Last Modified 07/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
60 and under
NCI
MDA-DM-94077
NCI-G96-1000, NCT00002832
Last Modified:
11/1/1994
4.
Phase II Study of Decitabine in Hormone-Refractory Stage D2 Prostate Cancer (Summary Last Modified 11/94)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Completed
over 18
NCI-94-C-0002A
NCI-CPB-332
Last Modified:
7/12/2007
 
First Published:
8/1/1998
5.
Phase II Study of Decitabine for Myelodysplastic Syndromes (Summary Last Modified 12/2001)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
15 and over
NCI
MSKCC-98017
NCI-G98-1444, NCT00003361
Last Modified:
5/1/1989
6.
Phase II Chemotherapy with 5-Aza-dCyd in Patients with Recurrent or Metastatic Squamous Cell Cancer of the Uterine Cervix (Summary Last Modified 05/89)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 to 75
EORTC-55857
7.
Phase II Trial of 5-Aza-2'-deoxycytidine in Patients with Advanced Squamous Cell Carcinoma, Adenocarcinoma, and Large Cell Carcinoma of the Lung
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
75 and under
EORTC-16851C
8.
Phase II Chemotherapy with 5-AZA-2'-Deoxycytidine in Patients with Relapsed or Refractory Stage III/IV Hodgkin's Disease
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
over 15
EORTC-20861
9.
Phase II Study of Chemotherapy with 5-Aza-2'-Deoxycytidine in Patients with Advanced Epithelial Cancer of the Ovary
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
70 and under
EORTC-16851G
Last Modified:
5/1/1988
10.
Phase II Chemotherapy with 5-Aza-2'-deoxycytidine in Patients with Nonseminomatous Testicular or Extragonadal Germ Cell Tumors That Are Progressive, Measurable, and Metastatic (Summary Last Modified 05/88)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
any age
EORTC-30871
Select All on One Page
1
2
3
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute